Previous 10 | Next 10 |
Summary Three things I look for when looking at companies. 2022: It was all about Renren. 2023: What ideas are out there? YCharts Best Ideas Each year, I highlight one top position as a best idea for the subsequent year. This year, the idea has been...
Abiomed ( NASDAQ: ABMD ) ticked up 1% in premarket trading after the antitrust waiting period for its sale to Johnson & Johnson ( NYSE: JNJ ) expired. The required waiting period under the HSR act expired on Wednesday, according to a regulatory filing. Johnson ...
Summary Johnson & Johnson announced that it will acquire Abiomed for $380 per share in cash, and will close before the end of the first quarter of 2023. With Abiomed's gross margins of 82%, higher than Johnson & Johnson's, JNJ's gross margin will increase after the merger. T...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...
NEW YORK, NY / ACCESSWIRE / November 20, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Peoples Bancorp Inc. (NASDAQ:PEB...
NEW YORK, NY / ACCESSWIRE / November 18, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Limestone Bancorp, Inc. (NASDAQ:...
NEW YORK, NY / ACCESSWIRE / November 17, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Limestone Bancorp, Inc. (NASDAQ:...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Election Day is finally here! The stock market rallied yesterday and today, but I believe this strength is the quiet before the storm. It is widely anticipated that the Republicans will take control of Congress, and if th...
Summary Johnson & Johnson has steadily been growing the business. After having deleveraged its balance sheet, the company announced a $16.6 billion deal for Abiomed. This deal and spin-off of the consumer health business, aimed to isolate liabilities, creates comfort for i...
NEW YORK, NY / ACCESSWIRE / November 6, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Altra Industrial Motion Corp. (NA...
News, Short Squeeze, Breakout and More Instantly...
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...